Dossier
personalized gene-editing drugs
Coverage of personalized gene-editing drugs in the Nexus archive.
- STAT+: Startup promising to scale custom CRISPR therapies abruptly scraps plans
Aurora Therapeutics, a startup focused on personalized gene-editing drugs, has scrapped its lead program and reduced staff, reportedly due to competition from Beam Therapeutics, which advanced similar therapies for the same disease.